Medical Condition News

RSS

Diffusion tensor imaging detects brain abnormalities in U.S. military personnel with mild traumatic brain injury

An advanced imaging technique has revealed that some U.S. military personnel with mild blast-related traumatic brain injuries have abnormalities in the brain that have not been seen with other types of imaging.

2 Jun 2011

Insecure people experience more conflict in sexual life

People who feel secure in in their relationship with their partner have a more satisfactory sex life and are more able to be sensitive in the affection they give. However, people who are insecure, who tend towards anxiety or avoidance and are compulsive or controlling in their affection experience more conflict in their sexual desire and are less happy in their relationships, according to a study by the University of the Basque Country.

2 Jun 2011

Individuals with hair loss can benefit from Sequencing technique

Hair loss remains an important distressing side effect for certain patients and individuals and although there are certainly more critical health issues there is no doubt that loss of hair is a stressful experience for men and women.

2 Jun 2011

Symphogen's rozrolimupab Phase 2 data to be presented at European Hematology Association meeting

Symphogen announced today that Phase 2 data will be presented from an open-label, multi-center clinical trial evaluating the safety and tolerability of rozrolimupab in adult, RhD positive, non-splenectomized patients with Immune thrombocytopenia (ITP) at the 16th Congress of the European Hematology Association meeting in London, UK on June 10 from 5:45 to 7:00 PM.

2 Jun 2011

WHO/IARC say mobile phone use may increase risk of certain brain cancers

Mobile phone use "may increase the risk of certain types of brain cancer in humans," therefore "consumers should consider ways of reducing their exposure," a WHO/International Agency for Research on Cancer (IARC) working group concluded on Tuesday, Reuters reports.

2 Jun 2011

Cell phone use poses no cancer risk, says JunkScience publisher

Today's media hoopla about the World Health Organization classifying cell phone use as "possibly carcinogenic" is much ado about nothing. The studies the WHO relies on are weak association studies that have zero reliability.

2 Jun 2011

Child casualties rise significantly in Somalia, WHO says

The WHO on Tuesday said children under age 5 make up almost half of those injured in a recent upsurge of violence in the Somali capital of Mogadishu, AlertNet reports.

2 Jun 2011

Researchers explore relationship between emotions and poor prognosis in heart disease

Intense distress and fear of dying, which many people experience when suffering the symptoms of a heart attack, are not only fairly common emotional responses but are also linked to biological changes that occur during the event, according to new research published online today in the European Heart Journal.

2 Jun 2011

RegeneRx Thymosin beta 4 stimulates maturation of central nervous system progenitor cells

RegeneRx Biopharmaceuticals, Inc. has announced that researchers have found that Thymosin beta 4 (Tβ4), in a dose dependent manner, stimulates oligodendrogenesis, the process by which central nervous system progenitor cells become oligodendrocytes that secrete myelin, the covering of nerve fibers.

2 Jun 2011

Repligen announces completion of RG1068 pre-New Drug Application meeting with U.S. FDA

Repligen Corporation today announced that the Company has concluded a pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration related to its lead product candidate, RG1068 for improvement of magnetic resonance imaging of the pancreas.

2 Jun 2011

Positive results from Nuvilex European Phase II trial against pancreatic cancer

Nuvilex, Inc. announces the favorable results of a completed Phase II clinical trial carried out in Europe against pancreatic cancer. The treatment technology used in this trial was recently acquired by Nuvilex.

2 Jun 2011

Patients with advanced NSCLC can benefit from less toxic combination of erlotinib, bevacizumab

The standard treatment for patients with advanced non-small cell lung cancer is a combination of two old-fashioned cytotoxic chemotherapy drugs. The combination, however, comes with substantial toxicity.

2 Jun 2011

Experts from 16 national osteoporosis societies to meet in Dubai for IOF event

Online registration and abstract submission is now open for the largest bone meeting of 2011 to be held in the Middle-East and Africa region.

2 Jun 2011

Teva receives FDA approval to market Eisai's Alzheimer's treatment Aricept Tablets in the U.S.

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has granted approval for the Company's Abbreviated New Drug Application to market a generic version of Eisai's Alzheimer's treatment Aricept Tablets, 5 mg and 10 mg. Shipment of this product has commenced.

2 Jun 2011

Five organizations receive IASLC travel awards to attend 14th World Conference on Lung Cancer

Five advocacy organizations from India, Australia and the United States have been granted travel awards by the International Association for the Study of Lung Cancer (IASLC) to send representatives to the 14th World Conference on Lung Cancer, July 3-7 in Amsterdam.

2 Jun 2011

New model can help determine physical fitness and cardiac health

Imagine being able to calculate one number that would tell you just how fit you are - and what that means for your heart health. Researchers from the Norwegian University of Science and Technology (NTNU) have managed exactly that: they have developed a model that can help doctors - and individuals - determine just how fit an individual is, and what that means for overall health.

2 Jun 2011

Free online WHO Fracture Risk Assessment Tool now available as version 3.3

The WHO Fracture Risk Assessment Tool (FRAX-) is an important new calculation tool, available free online at http://www.shef.ac.uk/FRAX, that is being used by a steadily increasing number of physicians around the world to calculate a patient's 10-year probability of fracture based on scientifically validated risk factors.

2 Jun 2011

IMS Model to guide providers and patients toward adherence

Physicians can help their patients follow prescribed treatments and achieve healthier results - particularly in chronic disease management - by using a three-pronged strategy developed by a team of researchers from the University of California, Riverside, Texas State University-San Marcos, and La Sierra University in Riverside, Calif.

2 Jun 2011

Baseline concussion tests could increase risks to athletes

Baseline concussion tests given to hundreds of thousands of athletes might, paradoxically, increase risks in some cases, according to a Loyola University Health System researcher.

2 Jun 2011

Study finds notable prevalence of childhood abuse in migraine patients

A notable prevalence of childhood abuse - physical, sexual, verbal, or emotional - in migraine patients has been observed and documented over the last few years. In fact, it has emerged as a significant enough issue for the American Headache Society to devote an entire plenary session to it at its annual scientific conference in Washington this week.

2 Jun 2011

Medical Condition News

Diffusion tensor imaging detects brain abnormalities in U.S. military personnel with mild traumatic brain injury

Insecure people experience more conflict in sexual life

Individuals with hair loss can benefit from Sequencing technique

Symphogen's rozrolimupab Phase 2 data to be presented at European Hematology Association meeting

WHO/IARC say mobile phone use may increase risk of certain brain cancers

Cell phone use poses no cancer risk, says JunkScience publisher

Child casualties rise significantly in Somalia, WHO says

Researchers explore relationship between emotions and poor prognosis in heart disease

RegeneRx Thymosin beta 4 stimulates maturation of central nervous system progenitor cells

Repligen announces completion of RG1068 pre-New Drug Application meeting with U.S. FDA

Positive results from Nuvilex European Phase II trial against pancreatic cancer

Patients with advanced NSCLC can benefit from less toxic combination of erlotinib, bevacizumab

Experts from 16 national osteoporosis societies to meet in Dubai for IOF event

Teva receives FDA approval to market Eisai's Alzheimer's treatment Aricept Tablets in the U.S.

Five organizations receive IASLC travel awards to attend 14th World Conference on Lung Cancer

New model can help determine physical fitness and cardiac health

Free online WHO Fracture Risk Assessment Tool now available as version 3.3

IMS Model to guide providers and patients toward adherence

Baseline concussion tests could increase risks to athletes

Study finds notable prevalence of childhood abuse in migraine patients

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News